Related Experiment Videos
Interleukin-6 does not activate protein breakdown in rat skeletal muscle
C García-Martínez1, F J López-Soriano, J M Argilés
1Department de Bioquimica i Fisiologia, Facultat de Biologia, Universitat de Barcelona, Spain.
Cancer Letters
|January 15, 1994
Summary
Interleukin-6 (IL-6) does not alter muscle protein synthesis or breakdown in rat muscles. This study concludes IL-6 is not responsible for changes in muscle protein turnover during sepsis.
Area of Science:
- Biochemistry
- Physiology
- Molecular Biology
Background:
- Sepsis can lead to muscle wasting and altered protein turnover.
- Interleukin-6 (IL-6) is a cytokine implicated in inflammatory responses.
- The role of IL-6 in sepsis-induced muscle catabolism requires clarification.
Purpose of the Study:
- To investigate the direct effect of recombinant human interleukin-6 (rIL-6) on muscle protein synthesis and breakdown.
- To determine if IL-6 mediates changes in muscle protein turnover during sepsis.
Main Methods:
- Isolated rat soleus and extensor digitorum longus (EDL) muscles were incubated with rIL-6.
- Protein breakdown was assessed by measuring tyrosine release.
- Protein synthesis and amino acid uptake were measured using alpha-(methyl)-aminoisobutyric acid (MeAIB).
Main Results:
- rIL-6 did not significantly alter the rate of protein breakdown (tyrosine release) in either soleus or EDL muscles.
- The presence of rIL-6 did not affect protein synthesis rates.
- rIL-6 did not influence MeAIB uptake, indicating no effect on amino acid transport.
Conclusions:
- Interleukin-6 (IL-6) does not directly modulate muscle protein synthesis or breakdown in isolated rat muscles.
- IL-6 is unlikely to be the primary mediator of muscle protein turnover changes observed during sepsis in rats.